Search results

After a broadly optimistic and reform-driven 2024, this year saw momentum begin to shift once again for the global medical cannabis sector. In many markets, like the Czech Republic or the US, promising legislative reforms have been stalled, while other markets like Germany and Australia are...

Dr Simon Erridge, Head of Research, Curaleaf Clinic, reflects on some of the key findings published from the UK Medical Cannabis Patient Registry this year. As we look back on 2025, it’s been another year of deepening understanding about how medical cannabis is being used in the UK. Research...

A team of scientists testing the effects of CBD and THC on ovarian cancer cells have found that both show promising anti-cancer effects. While still in the early stages, researchers say these preliminary findings from the laboratory present an important opportunity to develop effective new...

In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really means...

The UK’s medical cannabis industry has nearly tripled in size since 2022, according to new Freedom of Information data offering the most comprehensive look into what is being prescribed in the UK to date. FOI figures, secured by Prohibition Partners and analysed by Business of Cannabis, have...

Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed. However, one thing remains clear: growth is the priority. As we heard repeatedly at this week’s Cannabis Health Symposium, the...

As a new review highlights significant gaps in the evidence base for medical cannabis, researchers have called for more rigorous studies and access to “balanced information” to support healthcare professionals and their patients. The authors of a new comprehensive review have concluded that...

UK cannabinoid-based medicines manufacturer, 113 Botanicals, is raising £2 million to help launch its first controlled-release capsule, designed to improve dosing consistency and expand options for patients and prescribers. Working in partnership with scientists at the University of Sussex...

Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study. The study, published in JAMA Internal Medicine and led by researchers at Albert Einstein College of Medicine and...

A new paper adds to growing calls for urgent improvements in police training on how to respond to patients prescribed cannabis-based medicines. The research explores how regulations introduced in 2018, making it legal for specialists to prescribe medical cannabis, have not been ‘consistently...

The Medical Cannabis Clinicians Society (MCCS) has released a landmark guide setting out standardised dosing protocols for cannabis oils, in what the organisation describes as a major step forward for safe, consistent prescribing across the UK. The publication, which officially launched at the...

The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK. These in-depth talks spanned everything from pharmacy standards...

On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s collective drive to push beyond its own...

In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really...

Medical Cannabis Awareness Week has expanded for 2025, with an entire month of momentum-building events and educational initiatives, as organisations in the sector mark seven years since the law change. Over the last few years, Medical Cannabis Awareness Week has become an important date in...

Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still needed. This month, Releaf Cannabis Clinic published one of the most comprehensive surveys of UK medical cannabis...

Medical cannabis patients made history with a patient-led educational event about cannabis-based medicines, held at the Charterhouse in London. The international patient-led organisation We, The Patients, brought its educational event series to London for the first time on Friday 7 November, in...

In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really...

A large UK study suggests that people who use cannabis to self-medicate for pain or anxiety may be more likely to experience paranoia, prompting calls for improved patient monitoring in private prescribing. Researchers from King’s College London recently published the first findings from the...

From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? In the face of long NHS waiting lists and a lack of options in mainstream healthcare, many women are turning to...